Merck Serono and Pharmaron Partner in Beijing Lab

Merck Serono, the biopharma division of Germany’s Merck KGaA, announced a strategic partnership with Pharmaron, the US-China CRO. Pharmaron has opened a new Beijing facility that will be Merck Serono’s China R&D lab. It will be tasked with developing new drugs for cancer and neurodegenerative diseases. Pharmaron is supplying Merck Serono with staff, as well as the physical facilities. More details.... Stock Symbol: (XE: MRK)     Share this with colleagues: